STAAR to buy out Canon Staar

Article

STAAR Surgical has entered into an agreement to acquire the interests of all other shareholders in Canon Staar.

STAAR Surgical has entered into an agreement to acquire the interests of all other shareholders in Canon Staar, a joint venture that was formed by STAAR, Canon and Canon Marketing Japan.

Canon Staar was created to develop, manufacture and sell in Japan, products using STAAR's technology. At closing, STAAR will pay to the Canon companies $4 million in cash and $1.7 million newly issued shares of Series A Convertible Preferred Stock. This stock will be convertible into common stock at a one-to-one ratio and, under certain circumstances, will be redeemable for cash at $4 per share.

Canon Staar currently manufactures and sells the Preloaded Injector, a silicone or acrylic intraocular lens packaged and shipped in a pre-sterilized, disposable injector ready for use in cataract surgery.

On closing, the company will be renamed STAAR Japan and will become a wholly-owned subsidiary of STAAR.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.